Status:
COMPLETED
Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection
Lead Sponsor:
Perspectum
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
A prospective, longitudinal, observational cohort study looking at patients following COVID-19 disease using multi-parametric magnetic resonance imaging (MRI) to assess the degree and prevalence of or...
Detailed Description
To date, correctly, all of the Government's efforts have been dedicated to providing sufficient hospital space, and the appropriate equipment, for treating the most serious cases of COVID-19. Equally,...
Eligibility Criteria
Inclusion
- Male or female 18 years of age and older willing and able to give informed consent to participate in the study
- Recent confirmed diagnosis of SARS-CoV-2 RNA via a polymerase chain reaction (PCR) assay (having been discharged 7 or more days from hospital).
Exclusion
- Symptoms of active respiratory viral infection:
- high temperature (over 37.8C/100.04F)
- cough (consistent for over an hour; 3 or more episodes in 24 hours)
- The participant may not enter the study with any known contraindication to magnetic resonance imaging (including but not limited to pregnancy, a pacemaker or other metallic unfixed implanted device, metallic fragments, extensive tattoos, severe claustrophobia).
- Any other cause, including a significant underlying disease or disorder which, in the opinion of the investigator, may put the participant at risk by participating in the study or limit the participant's ability to participate.
Key Trial Info
Start Date :
April 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 19 2022
Estimated Enrollment :
693 Patients enrolled
Trial Details
Trial ID
NCT04369807
Start Date
April 21 2020
End Date
April 19 2022
Last Update
December 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Healthcare
London, United Kingdom, W1B 1PT
2
Gemini
Oxford, United Kingdom, OX4 2LL